Immunohistochemistry (IHC) analysis of Ki-67 expression, a marker for tumor cell proliferation, revealed markedly lower Ki-67 levels in itraconazole-treated tumors compared to controls (Figure 1F). This evidence concerns the gene MKI67 and neoplasm.